|
|||||
|
|
From the Medical Board of the National Psoriasis Foundation: The risk of cardiovascular disease in individuals with psoriasis and the potential impact of current therapies |
|
| Authors: | Jeremy Hugh Abby S. Van Voorhees Rajiv I. Nijhawan Jerry Bagel Mark Lebwohl Andrew Blauvelt Sylvia Hsu Jeffrey M. Weinberg |
| Affiliation: | 1. Department of Dermatology, St Luke’s-Roosevelt Hospital Center, New York, New York;2. Department of Dermatology, University of Pennsylvania, Philadelphia, Pennsylvania;3. Psoriasis Treatment Center of Central New Jersey, East Windsor, New Jersey;4. Department of Dermatology, Mount Sinai School of Medicine, New York, New York;5. Oregon Medical Research Center, Portland, Oregon;6. Department of Dermatology, Baylor College of Medicine, Houston, Texas |
| Abstract: | |
| Keywords: | adalimumab biologic therapies cardiovascular cyclosporine etanercept infliximab methotrexate mycophenolate mofetil psoralen plus ultraviolet A psoriasis ultraviolet therapy ustekinumab |
| 本文献已被 ScienceDirect 等数据库收录！ | |